How Safe Are Migraine Drugs for People With Cardiovascular Conditions?
Triptans were associated with fewer major adverse cardiovascular events (MACE) in acute migraine patients with a history of cardiovascular conditions compared with nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids/butalbital, patient registry data showed. Among people with acute migraine and at least one baseline cardiovascular condition, MACE occurred with 0.90% of triptan prescriptions, 4.52% of opioid/butalbital prescriptions, […]